Feasibility of biomarker studies for engineered nanoparticles: What can be learned from air pollution research

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 6 SUPPL., 2011, Pages

  Li, Ning ^a   Nel, Andre E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHITINASE; COMPLEMENT COMPONENT C3; CYTOKINE; CYTOKINE RECEPTOR; GLUTATHIONE; NANOPARTICLE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN YM 1; PROTEIN YM 2; UNCLASSIFIED DRUG;

AIR POLLUTION; CARDIOVASCULAR SYSTEM; FEASIBILITY STUDY; HUMAN; IMMUNE RESPONSE; METHODOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PROTEOMICS; RESPIRATORY SYSTEM; REVIEW;

EID: 79959254847     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31821b1bf2     Document Type: Review

References (79)

1. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627. (Pubitemid 43191298)
2. Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of engineered nanoparticles. J Occup Environ Hyg. 2008;5:239-249.
3. Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, McKernan JL. Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J Occup Environ Med. 2009;51:323-335.
4. Schulte PA, Trout D, Zumwalde RD, et al. Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science. J Occup Environ Med. 2008;50:517-526. (Pubitemid 351677634)
5. Merget R, Bauer T, Kupper HU, et al. Health hazards due to the inhalation of amorphous silica. Arch Toxicol. 2002;75:625-634. (Pubitemid 34151149)
6. Buchte SF, Morfeld P, Wellmann J, Bolm-Audorff U, McCunney RJ, Piekarski C. Lung cancer mortality and carbon black exposure: a nested case-control study at a German carbon black production plant. J Occup Environ Med. 2006;48:1242-1252. (Pubitemid 44967438)
7. Wellmann J, Weiland SK, Neiteler G, Klein G, Straif K. Cancer mortality in German carbon black workers 1976-98. Occup Environ Med. 2006;63:513-521.
8. Fahmy B, Cormier SA. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro. 2009;23:1365-1371.
9. Antonini JM. Health effects of welding. Crit Rev Toxicol. 2003;33:61-103. (Pubitemid 36183092)
10. Antonini JM, Lewis AB, Roberts JR, Whaley DA. Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Ind Med. 2003;43:350-360. (Pubitemid 36418215)
11. Luo JC, Hsu KH, Shen WS. Inflammatory responses and oxidative stress from metal fume exposure in automobile welders. J Occup Environ Med. 2009;51:95-103.
12. Xia T, Li N, Nel AE. Potential Health Impact of Nanoparticles. Annu Rev Public Health. 2009;30:137-150.
13. Antonini JM, Stone S, Roberts JR, et al. Effect of short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and defense responses in rats. Toxicol Appl Pharmacol. 2007;223:234-245. (Pubitemid 47362221)
14. Bydash J, Kasmani R, Naraharisetty K. Metal fume-induced diffuse alveolar damage. J Thorac Imaging. 2010;25:W27-W29.
15. Cooper RG. Zinc toxicology following particulate inhalation. Indian J Occup Environ Med. 2008;12:10-13.
16. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89-95.
17. Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol. 2007;18:565-571.
18. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. Nanotoxicology. Occup Environ Med. 2004;61:727-728. (Pubitemid 39178799)
19. Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med. 2008;44:1689-1699.
20. Stone V, Johnston H, Clift MJ. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience. 2007;6:331-340. (Pubitemid 350210539)
21. Balakrishna S, Lomnicki S, McAvey KM, Cole RB, Dellinger B, Cormier SA. Environmentally persistent free radicals amplify ultrafine particle mediated cellular oxidative stress and cytotoxicity. Part Fibre Toxicol. 2009;6:11-24.
22. Li R, Ning Z, Majumdar R, et al. Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: implication of chemical components and NF-kappa B signaling. Part Fibre Toxicol. 2010;7:6-17.
23. Araujo JA, Barajas B, Kleinman M, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102:589-596. (Pubitemid 351416760)
24. Li N, Sioutas C, Cho A, et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455-460. (Pubitemid 36546522)
25. Mo Y, Wan R, Chien S, Tollerud DJ, Zhang Q. Activation of endothelial cells after exposure to ambient ultrafine particles: the role of NADPH oxidase. Toxicol Appl Pharmacol. 2009;236:183-193.
26. Weissenberg A, Sydlik U, Peuschel H, et al. Reactive oxygen species as mediators of membrane-dependent signaling induced by ultrafine particles. Free Radic Biol Med. 2010;49:597-605.
27. Li N, Harkema JR, Lewandowski RP, et al. Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flares. Am J Physiol Lung Cell Mol Physiol. 2010;299:L374-L383.
28. Duvall RM, Norris GA, Dailey LA, et al. Source apportionment of particulate matter in the U.S. and associations with lung inflammatory markers. Inhal Toxicol. 2008;20:671-683. (Pubitemid 351890366)
29. Li N, Wang M, Bramble LA, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect. 2009;117:1116-1123.
30. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health. 2001;74:1-8. (Pubitemid 32123735)
31. Peters A, Veronesi B, Calderon-Garciduenas L, et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol. 2006;3:13-25.
32. Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008;26:339-362. (Pubitemid 352790465)
33. MacNee W, Donaldson K. How can ultrafine particles be responsible for increased mortality? Monaldi Arch Chest Dis. 2000;55:135-139. (Pubitemid 30315874)
34. Araujo JA, Nel AE. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part Fibre Toxicol. 2009;6:24-42.
35. Delfino RJ, Sioutas C, Malik S. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect. 2005;113:934-946. (Pubitemid 41149620)
36. Mills NL, Donaldson K, Hadoke PW, et al. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med. 2009;6:36-44.
37. Mills NL, Tornqvist H, Robinson SD, et al. Air pollution and atherothrombosis. Inhal Toxicol. 2007;19:81-89. (Pubitemid 47450691)
38. Scapellato ML, Lotti M. Short-term effects of particulate matter: an inflammatory mechanism? Crit Rev Toxicol. 2007;37:461-487. (Pubitemid 47174573)
39. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology. 2007;230:90-104. (Pubitemid 46073330)
40. Warheit DB, Reed KL, Sayes CM. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal Toxicol. 2009;21:61-67.
41. Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ Sci Technol. 2009;43:7939-7945.
42. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97:163-180. (Pubitemid 47072165)
43. Hussain S, Boland S, Baeza-Squiban A, et al. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology. 2009;260:142-149.
44. Liang G, Pu Y, Yin L, et al. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A. 2009;72:740-745.
45. Park EJ, Yi J, Chung KH, Ryu DY, Choi J, Park K. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett. 2008;180:222-229.
46. Sayes CM, Wahi R, Kurian PA, et al. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci. 2006;92: 174-185. (Pubitemid 43994876)
47. Park EJ, Choi J, Park YK, Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology. 2008;245:90-100.
48. Madl AK, Pinkerton KE. Health effects of inhaled engineered and incidental nanoparticles. Crit Rev Toxicol. 2009;39:629-658.
49. Karlsson HL, Cronholm P, Gustafsson J, Moller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. 2008;21:1726-1732.
50. Karlsson HL, Gustafsson J, Cronholm P, Moller L. Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol Lett. 2009;188:112-118.
51. Ahamed M, Siddiqui MA, Akhtar MJ, Ahmad I, Pant AB, Alhadlaq HA. Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Biophys Res Commun. 2010;396:578-583.
52. Yu M, Mo Y, Wan R, Chien S, Zhang X, Zhang Q. Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles. Toxicol Lett. 2010;195:82-89.
53. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121-2134.
54. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010;4:15-29.
55. Kang GS, Gillespie PA, Gunnison A, Moreira AL, Tchou-Wong KM, Chen LC. A Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model. Environ Health Perspect. 2011;119:176-181.
56. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K. Inflammatory responses may be induced by a single intratracheal instillation of iron nanoparticles in mice. Toxicology. 2010;275:65-71.
57. Fujita K, Morimoto Y, Ogami A, et al. Gene expression profiles in rat lung after inhalation exposure to C60 fullerene particles. Toxicology. 2009;258:47-55.
58. Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials. 2010;31:8198-8209.
59. Xia T, Kovochich M, Brant J, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006;6:1794-1807.
60. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes inmice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L698-L708. (Pubitemid 41504399)
61. Crouzier D, Follot S, Gentilhomme E, et al. Carbon nanotubes induce inflammation but decrease the production of reactive oxygen species in lung. Toxicology. 2010;272:39-45.
62. Delfino RJ, Staimer N, Tjoa T, et al. Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology. 2010;21:892-902.
63. Grahame TJ, Schlesinger RB. Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence. Air Qual Atmos Health. 2010;3:3-27.
64. Delfino RJ, Staimer N, Tjoa T, et al. Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspect. 2009;117:1232-1238.
65. Delfino RJ, Staimer N, Tjoa T, et al. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect. 2008;116:898-906. (Pubitemid 351943897)
66. Laumbach RJ, Kipen HM. Acute effects of motor vehicle traffic-related air pollution exposures on measures of oxidative stress in human airways. Ann N Y Acad Sci. 2010;1203:107-112.
67. Liu L, Poon R, Chen L, et al. Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. Environ Health Perspect. 2009;117:668-674.
68. Duramad P, Tager IB, Holland NT. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett. 2007;172:48-59. (Pubitemid 47126222)
69. Jung EJ, Avliyakulov NK, Boontheung P, Loo JA, Nel AE. Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics. 2007;7:3906-3918. (Pubitemid 350100007)
70. Kang X, Li N, Wang M, et al. Adjuvant effects of ambient particulate matter monitored by proteomics of bronchoalveolar lavage fluid. Proteomics;10: 520-531.
71. Xiao GG, Wang M, Li N, Loo JA, Nel AE. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem. 2003;278:50781-50790. (Pubitemid 37548927)
72. Zhang L, Wang M, Kang X, et al. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res. 2009;8:1631-1638.
73. Sheehan D. The potential of proteomics for providing new insights into environmental impacts on human health. Rev Environ Health. 2007;22:175-194. (Pubitemid 350080396)
74. Lau AT, Chiu JF. Biomarkers of lung-related diseases: current knowledge by proteomic approaches. J Cell Physiol. 2009;221:535-543.
75. Xu NY, Zhang SP, Dong L, Nie JH, Tong J. Proteomic analysis of lung tissue of rats exposed to cigarette smoke and radon. J Toxicol Environ Health A. 2009;72:752-758.
76. Chang CC, Chen SH, Ho SH, Yang CY, Wang HD, Tsai ML. Proteomic analysis of proteins from bronchoalveolar lavage fluid reveals the action mechanism of ultrafine carbon black-induced lung injury in mice. Proteomics. 2007;7:4388-4397.
77. Kang X, Li N, Wang M, et al. Adjuvant effects of ambient particulate matter monitored by proteomics of bronchoalveolar lavage fluid. Proteomics. 2010;10:520-531.
78. de Torre C, Ying SX, Munson PJ, Meduri GU, Suffredini AF. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics. 2006;6:3949-3957. (Pubitemid 44081167)
79. Wang M, Xiao GG, Li N, Xie Y, Loo JA, Nel AE. Use of a fluorescent phosphoprotein dye to characterize oxidative stress-induced signaling pathway components in macrophage and epithelial cultures exposed to diesel exhaust particle chemicals. Electrophoresis. 2005;26:2092-2108. (Pubitemid 40852641)